Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Immucell Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 26 | 26 | 0 |
| Shares | 971.4K | 982.1K | +10.7K (+1.1%) |
| Value | $7.26M | $5.41M | −$1.86M (−25.6%) |
New holders (1)
Institutions that held Immucell Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,276 | $8.00K | 0.00% |
Sold out (1)
Institutions that held Immucell Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Prosperity Planning, Inc. | 16,000 | $120.0K |